BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 28782777)

  • 1. An efficient one-pot approach for the regio- and diastereoselective synthesis of trans-dihydrofuran derivatives: cytotoxicity and DNA-binding studies.
    Tangella Y; Manasa KL; Laxma Nayak V; Sathish M; Sridhar B; Alarifi A; Nagesh N; Kamal A
    Org Biomol Chem; 2017 Aug; 15(32):6837-6853. PubMed ID: 28782777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, antitumor activity evaluation, and DNA-binding study of coumarin-based agents.
    Amin KM; Taha AM; George RF; Mohamed NM; Elsenduny FF
    Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29148081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,2,3-Triazole Tagged 3H-Pyrano[2,3-d]pyrimidine-6-carboxylate Derivatives: Synthesis, in Vitro Cytotoxicity, Molecular Docking and DNA Interaction Studies.
    Boda SK; Pishka V; Lakshmi PVA; Chinde S; Grover P
    Chem Biodivers; 2018 Jun; 15(6):e18000101. PubMed ID: 29660245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
    Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
    Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of new β-carboline-bisindole compounds as DNA binding, photocleavage agents and topoisomerase I inhibitors.
    Kovvuri J; Nagaraju B; Nayak VL; Akunuri R; Rao MPN; Ajitha A; Nagesh N; Kamal A
    Eur J Med Chem; 2018 Jan; 143():1563-1577. PubMed ID: 29129513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, cytotoxicity, HuTopoIIα inhibitory activity and molecular docking studies of pyrazole derivatives as potential anticancer agents.
    Alam R; Wahi D; Singh R; Sinha D; Tandon V; Grover A; Rahisuddin
    Bioorg Chem; 2016 Dec; 69():77-90. PubMed ID: 27744115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
    Ahmad P; Woo H; Jun KY; Kadi AA; Abdel-Aziz HA; Kwon Y; Rahman AF
    Bioorg Med Chem; 2016 Apr; 24(8):1898-908. PubMed ID: 26988802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro antiproliferative activity, and in silico studies of fused tricyclic coumarin sulfonate derivatives.
    El-Gamal MI; Oh CH
    Eur J Med Chem; 2014 Sep; 84():68-76. PubMed ID: 25016229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Molecular Docking and Biological Evaluation of Quinolone Derivatives as Novel Anticancer Agents.
    Li J; Zheng TC; Jin Y; Xu JG; Yu JG; Lv YW
    Chem Pharm Bull (Tokyo); 2018 Jan; 66(1):55-60. PubMed ID: 29118308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, cytotoxic activities, and DNA-binding studies of ternary copper(II) complexes with new coumarin derivatives.
    Jia L; Xu XM; Xu J; Chen LH; Jiang P; Cheng FX; Lu GN; Wang Q; Wu JC; Tang N
    Chem Pharm Bull (Tokyo); 2010 Aug; 58(8):1003-8. PubMed ID: 20686250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cytotoxic activity of non-naturally substituted 4-oxycoumarin derivatives.
    Serra S; Chicca A; Delogu G; Vázquez-Rodríguez S; Santana L; Uriarte E; Casu L; Gertsch J
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5791-4. PubMed ID: 22901895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structure and in vitro pharmacological evaluation of a novel 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (2'-methylbenzoyl) hydrazone bridged copper(II) coordination polymer.
    Senthil Raja D; Ramachandran E; Bhuvanesh NS; Natarajan K
    Eur J Med Chem; 2013 Jun; 64():148-59. PubMed ID: 23644198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization and in vitro anticancer evaluation of novel 1,2,4-triazolin-3-one derivatives.
    Kattimani PP; Kamble RR; Kariduraganavar MY; Dorababu A; Hunnur RK
    Eur J Med Chem; 2013 Apr; 62():232-40. PubMed ID: 23353755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies.
    El-Adl K; Ibrahim MK; Alesawy MSI; Eissa IH
    Bioorg Med Chem; 2021 Jan; 30():115958. PubMed ID: 33360576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents.
    Yadagiri B; Holagunda UD; Bantu R; Nagarapu L; Kumar CG; Pombala S; Sridhar B
    Eur J Med Chem; 2014 May; 79():260-5. PubMed ID: 24742385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mono- and bis-pyrazolophthalazines: Design, synthesis, cytotoxic activity, DNA/HSA binding and molecular docking studies.
    Hamidinasab M; Ameri A; Hekmat A; Forootanfar H; Mortezazadeh T; Bodaghifard MA; Peytam F; Esmaeili R; Foroumadi A; Sharifzadeh M; Mobinikhaledi A; Khoobi M
    Bioorg Med Chem; 2021 Jan; 30():115944. PubMed ID: 33352388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies.
    Menteşe E; Güner A; Polatlı E; Emirik M; Bektaş H; Kahveci B
    Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000284. PubMed ID: 33146895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, DNA interactions, DNA cleavage, radical scavenging activity, antibacterial, anti-proliferative and docking studies of new transition metal complexes.
    Chennam KP; Ravi M; Ushaiah B; Srinu V; Eslavath RK; Devi ChS
    J Fluoresc; 2016 Jan; 26(1):189-205. PubMed ID: 26545354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
    An R; Hou Z; Li JT; Yu HN; Mou YH; Guo C
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30200625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Antitumor Evaluation of Some Hybrid Molecules Containing Coumarin and Quinolinone Moieties.
    Rizzk YW; El-Deen IM; Mohammed FZ; Abdelhamid MS; Khedr AIM
    Anticancer Agents Med Chem; 2019; 19(16):2010-2018. PubMed ID: 31566140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.